SCHEMBL16051297

SCHEMBL16051297

Nc1ccccc1C(=O)N1CCC(O)(Cc2ccccc2)CC1

nearest known ligand 0.69

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ AVPR1A P37288 4/20 0.69
▸ CYP46A1 Q9Y6A2 13/20 0.63
▸ CYP3A4 P08684 1/20 0.60
▸ CYP2C8 P10632 1/20 0.60
▸ CYP2C9 P11712 1/20 0.60
▸ CYP2C19 P33261 1/20 0.60
▸ AVPR1B P47901 1/20 0.49
▸ OPRM1 P35372 1/20 0.48
▸ OPRD1 P41143 1/20 0.48
▸ OPRK1 P41145 1/20 0.48
▸ OPRL1 P41146 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16049701 0.81 AVPR1A (0.58) AVPR1ACYP46A1CYP3A4CYP2C8CYP2C9
SCHEMBL23581415 0.80 AVPR1A (0.59) AVPR1ACYP46A1CYP3A4CYP2C8CYP2C9
SCHEMBL3833018 0.79 AVPR1A (0.62) AVPR1ACYP46A1CYP3A4CYP2C8CYP2C9
SCHEMBL14840498 0.79 CYP46A1 (0.69) AVPR1ACYP46A1CYP3A4CYP2C8CYP2C9
SCHEMBL14849013 0.78 CYP46A1 (1.00) AVPR1ACYP46A1CYP3A4CYP2C8CYP2C9
SCHEMBL11551933 0.78 DRD2 (0.49) AVPR1ACYP46A1OPRM1OPRD1OPRK1
SCHEMBL10663590 0.77 CA12 (0.67) —
SCHEMBL21977074 0.77 PKLR (0.54) AVPR1ACYP46A1CYP3A4CYP2C8CYP2C9
SCHEMBL22218935 0.77 CYP46A1 (0.78) AVPR1ACYP46A1CYP3A4CYP2C8CYP2C9
Hydrochloric Acid SCHEMBL11555132 0.77 AVPR1A (0.48) AVPR1ACYP46A1OPRM1OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970189-A1 THERAPEUTIC COMPOUNDS AND COMPOSITIONS Agios Pharmaceuticals, Inc. (US) 2016-01-20 — — EP disclosed
WO-2014139325-A1 THERAPEUTIC COMPOUNDS AND COMPOSITIONS AGIOS PHARMACEUTICALS, INC. (US) 2014-09-18 — — WO disclosed
Send feedback